$22.29
Price
$3.7B
Market Cap
—
P/E Ratio
36.5
Forward P/E
$-0.62
EPS (TTM)
—
Dividend Yield
$15M
Cash
$670M
Total Debt
165M
Shares Out
$10.43
$29.90
52-Week Range
Institutional Ownership of Rxo Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 43.7K | $1M | $18.19 | +29.33% |
Trading Activity for Rxo Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| SELL | -19.0% | 43.7K | $552760 | $14.51 | |
| 2024-Q2 | |||||
| BUY | +23.4% | 54.0K | $1M | $20.47 | |
| 2022-Q4 | |||||
| BUY | NEW | 43.7K | $752173 | $17.65 | |
Insider Trading for Rxo Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.